Get started

Covid19stock

NET - MOMENTUM TRADE SLINGSHOTCLOUDFLARE (NET) met expectations 2 days ago on my previous post and broke out from a Blue Sky Set-Up. It paused yesterday for profit taking and is currently set-up again to continue it's move to hit a round number target. Needham just raised its price target to 38, a mere 3% away from it's current price. NET is a clear beneficiary of the shift to work from home and e-commerce on increased demand for cybersecurity. The company provides an integrated cloud-based security solution to secure a range of combination of platforms, including public cloud, private cloud, on-premise, software-as-a-service applications, and Internet of Things (IoT) devices. Current set-up is a slingshot which could potentially result to another Bullish Marobozu similar to the breakout candle. Possibilities are: (1) it pauses for another day (today) with low volatility or (2) continue its range expansion and hit 38-40. Pauses can extend to three days with tightening ranges and decreasing volume indicating a healthy profit taking before proceeding to make an explosive move which is otherwise referred to as a Boomer Set-Up. Best approach to prevent early participation if explosive breakout doesn't materialize is to buy at the break of the yesterdays high supported by volume acceleration. This can clearly observed and managed on the 15-minute chart.
NYSE:NETLong
by TradingMavericks
IF COVID-19 Hits Again…What would happen if COVID-19 Hits again? If COVID-19 has another outbreak, we think we’ll go through the similar three phases the market went through since mid-February. Phase 1: Denial Phase 2: Fear & Market over-reaction Phase 3: Recovery However, we do believe the market impact would be smaller this time around. Some countries are still experiencing a high rate of daily discovered new cases and the negative impacts from these countries have already been priced in. The market sentiment would also be less fearful given the readily developed global COVID-19 awareness. To what degree will BTC be correlated with SPX? Best wishes to all of you! Stay safe and positive!
BITSTAMP:BTCUSDLong
by Phi-Deltalytics
61
NET : SLINGSHOT TO BOOMER SET UPCLOUDFLARE (NET) met breakout expectation from a Blue Sky set-up and is currently on a pause currently on Slingshot Set-up to potentially continue its range expansion. Needham just raised its price target to 38, a mere 3% away from its current price. NET is clearly a beneficiary to the work from home and e-commerce shift with increasing demand for cybersecurity. The company provides an integrated cloud-based security solution to secure a range of combination of platforms, including public cloud, private cloud, on-premise, software-as-a-service applications, and Internet of Things (IoT) devices. On technical analysis, a Slingshot set-up is a brief healthy profit taking with very little volatility which could result to another range expansion similar to the Bullish Marubozu breakout candle 2 days ago. If the expansion doesn't materialize today, the ranges can get tighter for 2 more days which could be a springboard to the potential expansion (Boomer Set-Up). To avoid opportunity cost, it's best to buy at the break of yesterdays high supported by volume acceleration. Price action is best observed and managed on the 15-min chart for ease of execution. Trade duration is as little a few hours to a day. If position is ahead and does not hit price target, sell half to protect gains and trail stop the balance on the 5-day EMA to minimize weekend risk. As always, risk first and profit second. Be aware of your risk profile and only risk what you can afford to lose.
NYSE:NETLong
by TradingMavericks
LVGO BLUE SKY BREAKOUT to BOOMER SET UPAnother beneficiary of the shift towards Telemedicine and remote health monitoring because of COVID-19. Company has been doing exceptionally well even before the pandemic with increased insurance support providing subscription to several Fortune 500 companies. Increased institutional participation observed with high quality funds increasing their position on the issue. Technicals breaking out of the pattern resistance with OBV indicating increased buying pressure and RSI signals strong momentum for range expansion after pausing on the second half of the trading day. ADX >30 also confirming trend strength. Boomer set up observed on 2H chart giving an opportunity to participate on expansion breakout.
LLong
by TradingMavericks
Bullish Charts - Oversold & Undervalued Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, such as cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; oncology, such as biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; licensing agreement with Akcea Therapeutics, Inc; strategic alliance with Verily Life Sciences LLC; collaboration agreement with Merck KGaA; clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; material transfer and collaboration agreement with BioNTech SE to co-develop COVID-19 vaccine; clinical supply collaboration Jiangsu Alphamab Biopharmaceuticals Co., Ltd; and collaboration with Valneva SE to develop and commercialize Valneva's Lyme disease vaccine candidate VLA15. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer is one of the most unappreciated stocks in its industry and the low price shows. Recently, institutions have taken notice and started upgrading the stock with price targets north of $40.00 a share. Pfizer is also working on a COVID-19 vaccine and could be months ahead of other companies. On the daily chart, the stock is sitting is sitting and bouncing off support around $33.00. It's ready for a move up any day. Long!
NYSE:PFELong
by HotCharts
BIOC Trying To Fill Gap But Can It This Time?Looks like Biocept BIOC is making another technical move on more information from the company's website about its COVID testing. Apparently people on social are talking about updates that the company is doing COVID testing now. Company site specifically stating: "To support public health efforts, Biocept is performing COVID-19 testing. If you’re in need of testing, please consult with your doctor or authorized healthcare provider as Biocept will need them to order and collect the specimen for COVID-19 testing, per FDA guidance." It's interesting that this is being pointed out. I looked at WayBackMachine and see some updates but nothing that drastic. Either way, it seems like it was enough to get the juices flowing for some people on twitter. Guess we'll see what happens next. Chart has been riding the same support and testing the upper end of that previous gap. Who's placing bets on the over (going up) or the under (coming back down)?
B
by PennyStocks101
Long on PK! Breakout to the next Daily Moving AverageLong on PK! Breakout to the next Daily Moving Average. COVID - 19 Vaccian developments with very promising news + The fed will support the industry with infinite money. Dividend Yield post covid-19 will be about 15% Annually. The price is stable with low volatility. The company has enough cash to operate for 18 months, and they will issue a bond to raise more cash. This is a sleeping money maker, unless you fear the Virus.
NYSE:PKLong
by Zordo